Molecular profiling in non-squamous non-small cell lung carcinoma: towards a switch to next-generation sequencing reflex testing
Molecular diagnosis of lung cancer is a constantly evolving field thanks to major advances in
precision oncology. The wide range of actionable molecular alterations in non-squamous …
precision oncology. The wide range of actionable molecular alterations in non-squamous …
Updates in pathology and molecular diagnostics to inform the evolving landscape of thoracic surgery and oncology
The pathologic assessment of lung cancers provides essential guidance to the surgeon and
oncologist who are considering the best treatment strategies for patients with both early and …
oncologist who are considering the best treatment strategies for patients with both early and …
Clinical utility and performance of an ultrarapid multiplex RNA-based assay for detection of ALK, ROS1, RET, and NTRK1/2/3 rearrangements and MET exon 14 …
Several kinase fusions are established targetable drivers in lung cancers. However, rapid
and comprehensive detection remains challenging because of diverse partner genes and …
and comprehensive detection remains challenging because of diverse partner genes and …
FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for …
A Behnke, A Cayre, G De Maglio… - Pathology and …, 2023 - por-journal.com
Accurate testing for epidermal growth factor receptor (EGFR) variants is essential for
informing treatment decisions in non-small cell lung cancer (NSCLC). Automated diagnostic …
informing treatment decisions in non-small cell lung cancer (NSCLC). Automated diagnostic …
Contribution of the IdyllaTM System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of EGFR Mutations
C Petiteau, G Robinet-Zimmermann, A Riot… - Current …, 2021 - mdpi.com
Epidermal growth factor receptor (EGFR) genotyping, a critical examen for the treatment
decisions of patients with non-small cell lung cancer (NSCLC), is commonly assayed by next …
decisions of patients with non-small cell lung cancer (NSCLC), is commonly assayed by next …
Utility of select gene mutation detection in tumors by the Idylla rapid multiplex PCR platform in comparison to next-generation sequencing
Testing of tumors by next generation sequencing (NGS) is impacted by relatively long
turnaround times and a need for highly trained personnel. Recently, Idylla oncology assays …
turnaround times and a need for highly trained personnel. Recently, Idylla oncology assays …
[HTML][HTML] Percutaneous image-guided biopsy for a comprehensive hybridization capture-based next-generation sequencing in primary lung cancer: safety, efficacy, and …
A Elsakka, EN Petre, F Ridouani, M Ghosn… - JTO Clinical and …, 2022 - Elsevier
Introduction To evaluate factors associated with successful comprehensive genomic
sequencing of image-guided percutaneous needle biopsies in patients with lung cancer …
sequencing of image-guided percutaneous needle biopsies in patients with lung cancer …
Idylla EGFR assay on extracted DNA: Advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) …
E Khalifa, C Chapusot, B Tournier, J Sentis… - Journal of Clinical …, 2023 - jcp.bmj.com
Aims Idylla epidermal growth factor receptor (EGFR) is a fast and fully automated mutation
assay that is easy to implement. However, under the Biocartis-recommended technical …
assay that is easy to implement. However, under the Biocartis-recommended technical …
Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers
P Gilson, C Saurel, J Salleron, M Husson… - Scientific Reports, 2021 - nature.com
The assessment of EGFR mutations is recommended for the management of patients with
non-small cell lung cancer (NSCLC). Presence of EGFR mutation is associated with …
non-small cell lung cancer (NSCLC). Presence of EGFR mutation is associated with …
The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2
MS Zhang, YC Yeh, HN Huang, LW Lin, YL Huang… - Plos one, 2024 - journals.plos.org
Determining the exact type of epidermal growth factor receptor (EGFR) exon 20 insertion
(ex20ins) mutation in lung cancer has become important. We found that not all ex20ins …
(ex20ins) mutation in lung cancer has become important. We found that not all ex20ins …